![Takahito Nakamura](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Takahito Nakamura
Gründer bei Kohjin BIO Co., Ltd.
Vermögen: 30 Mio $ am 31.05.2024
Profil
Takahito Nakamura is the founder of Kohjin Bio Co., Ltd.
He holds the title of President & Representative Director at the company since its founding in 1981.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
Kohjin BIO Co., Ltd.
![]() Kohjin BIO Co., Ltd. BiotechnologyHealth Technology Kohjin Bio Co., Ltd. engages in the manufacture and sale of animal blood, serums, tissue culture media and other products. It operates through the following business segments. Tissue Culture Business, Microbiology Business and Cell Processing Business. The Tissue Culture business segment engages in the manufactures, and sale of tissue culture media, including serum free media used for research purposes in regenerative medicine and immunotherapy. The Microbiology business segment develops, manufactures, and sells a wide variety of microorganism detection media used for pathogen testing in the clinical and food fields, and quality testing in various fields such as pharmaceuticals and cosmetics. The Cell Processing business segment conducts cell processing operations under contract from medical institutions. The company was founded by Takato Nakamura in April 1981 and is headquartered in Sakado, Japan. 51,37% | 25.04.2024 | 2 626 000 ( 51,37% ) | 30 Mio $ | 31.05.2024 |
Aktive Positionen von Takahito Nakamura
Unternehmen | Position | Beginn |
---|---|---|
Kohjin BIO Co., Ltd.
![]() Kohjin BIO Co., Ltd. BiotechnologyHealth Technology Kohjin Bio Co., Ltd. engages in the manufacture and sale of animal blood, serums, tissue culture media and other products. It operates through the following business segments. Tissue Culture Business, Microbiology Business and Cell Processing Business. The Tissue Culture business segment engages in the manufactures, and sale of tissue culture media, including serum free media used for research purposes in regenerative medicine and immunotherapy. The Microbiology business segment develops, manufactures, and sells a wide variety of microorganism detection media used for pathogen testing in the clinical and food fields, and quality testing in various fields such as pharmaceuticals and cosmetics. The Cell Processing business segment conducts cell processing operations under contract from medical institutions. The company was founded by Takato Nakamura in April 1981 and is headquartered in Sakado, Japan. | Gründer | 01.04.1981 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen